Hosein Shokouh-Amiri, MD
Transplant Surgery · Shreveport, LANPI 1831155688
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,051 of the $1,708 with a category attached, or 61.5%. Histosonics, Inc. accounts for 62.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $1,528 and has fallen 99.0% since, to $15 in 2025.
Across 12 payments — averaging $142.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Histosonics, Inc.$1K
- Eurofins Viracor, LLC$199
- Sanofi-aventis U.S. LLC$150
- Intuitive Surgical$112
- Olympus America Inc.$98
- Sanara Medtech Inc.$40
- plus $43 from 3 others
What the payments were for
- Travel & lodging$1,05162%
- Food & beverage$65738%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Histosonics, Inc. | 4 | $1,067 |
| Eurofins Viracor, LLC | 1 | $199 |
| Sanofi-aventis U.S. LLC | 1 | $150 |
| Intuitive Surgical | 1 | $112 |
| Olympus America Inc. | 1 | $98 |
| Sanara Medtech Inc. | 1 | $40 |
| Lemaitre Vascular, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Cook Medical LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few transplant surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 12 | $9,131 |
| Valganciclovir Hcl | 27 | $4,672 |
| Tacrolimus | 20 | $2,577 |
| Mycophenolate Mofetil | 16 | $1,066 |
| Fluconazole | 26 | $862 |
| Pantoprazole Sodium | 94 | $402 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $185 |
| Metoclopramide Hcl | 20 | $128 |
| Prednisone | 27 | $103 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Shreveport
- Donnie AultmanShreveport$1K
- Robert McMillanShreveport$1K
- Alana HofmannShreveport$107
- Anil ParameshMetairie$21K
- Lee CummingsMetairie$12K
- Adarsh VijayNew Orleans$8K
- Dennis Sonnier JrNew Orleans$7K
- Trine EngebretsenNew Orleans$4K
- Justin BarrNew Orleans$3K
- John SealNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.